Related Experiment Video
Updated: Sep 2, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Long-Term Cancer Recurrence Rates following Nipple-Sparing Mastectomy: A 10-Year Follow-Up Study
Carter J Boyd1, Ara A Salibian1, Jonathan M Bekisz1
1From the Hansjörg Wyss Department of Plastic Surgery and Division of Surgical Oncology, Department of Surgery, New York University Langone Health.
Nipple-sparing mastectomy shows low long-term breast cancer recurrence rates, with no identified risk factors for recurrence. Close patient surveillance is recommended to detect any potential recurrence promptly.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Surgery
Background:
- Nipple-sparing mastectomy (NSM) is increasingly used for breast cancer treatment.
- Limited data exist on long-term cancer recurrence rates following NSM.
Purpose of the Study:
- To analyze breast cancer recurrence rates in patients who underwent therapeutic NSM.
- To identify potential risk factors for locoregional recurrence after NSM.
Main Methods:
- Retrospective review of 126 therapeutic NSMs performed on 120 patients.
- Median follow-up of 10 years.
- Analysis of demographic factors, pathology findings, and oncologic outcomes; univariate analysis for risk factors.
Main Results:
- The overall recurrence rate was 3.17% per mastectomy and 3.33% per patient.
- Common histologies included invasive ductal carcinoma and ductal carcinoma in situ.
- No demographic, operative, or tumor-specific variables were independent risk factors for recurrence.
Conclusions:
- Therapeutic NSM demonstrates low long-term breast cancer recurrence rates.
- Close surveillance is crucial for early detection of recurrence in NSM patients.
More Related Videos
05:05Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017